Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows a minor system revision update from v3.4.1 to v3.4.2, with no changes to the study information, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1. This appears to be a minor version update with no changes to the study details or content.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded the glossary display and updated QC metadata to show Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while removing the older Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No substantive study details or user-facing features appear affected.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter/version notes updated: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page revision has been updated to v3.3.2, replacing the previous v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.